Randomised controlled trial of Omalizumab in treatment-resistant systemic And cutaneous Mastocytosis (ROAM)
- Author(s)
- McComish, JS; VARIGOS, GA; Slade, CA; Buizen, L; Paul, SK; Chatelier, JW; Unglik, G; Nicholls, KA; Spriggs, K; Chan, SS; Godsell, J; Auyeung, P; Tan, ZH; DeLuca, J; Patel, M; Kuek, BBiomed Hons LE; Tran, Y; Kern, JS; Scardamaglia, L; Juneja, S; Grabek, JA; Christie, M; Mackay, GA; Douglass, JA;
- Details
- Publication Year 2023-04-21,Volume 11,Issue #7,Page 2248-2250 e3
- Journal Title
- Journal of Allergy and Clinical Immunology In Practice
- Publisher
- Elsevier
- Keywords
- Humans; Omalizumab/therapeutic use; *Mastocytosis, Cutaneous/drug therapy; *Anti-Allergic Agents/therapeutic use; *Mastocytosis, Systemic/drug therapy; *Mastocytosis/drug therapy
- Research Division(s)
- Immunology
- PubMed ID
- 37088371/
- Publisher's Version
- https://doi.org/10.1016/j.jaip.2023.04.008
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-05-01 02:16:43
Last Modified: 2023-07-12 08:28:29